Interfaith Medical Center

Elma Center, NY, United States

Interfaith Medical Center

Elma Center, NY, United States

Time filter

Source Type

Akerele E.,Interfaith Medical Center | Yuryev A.,New York Medical College
International Journal of Mental Health | Year: 2017

The course is designed to train Humanitarian field staff in providing single-session psychotherapy in context of humanitarian situations. The participants of the course are expected to have basic background knowledge in mental health and psychotherapy. The course is typically focused on training of healthcare professionals providing counseling services in the field during humanitarian missions. Participants may include psychiatrists, psychologists, nurses, and clinical social workers. The course includes presentations of didactic material, clinical simulations and discussion based workshop. The course participants will acquire skills necessary to be able to do as follows: Identify individuals that are eligible for single session therapy; provide single-session psychotherapy in humanitarian situations; refer Individuals for additional help with appropriate tool kit. The theoretical part of the course (didactic presentation) requires around 45 min presentation followed by 30 min of question time. Clinical simulation requires two hours for each part. Discussion-based workshop requires two hours. Trainees will be evaluated based on their performance during the final clinical simulation part of the course. They will be certified upon successful completion of both didactic and clinical simulation exercises. © 2017 Taylor & Francis


Jegede O.O.,Interfaith Medical Center | Ahmed S.F.,Interfaith Medical Center | Olupona T.,Interfaith Medical Center | Akerele E.,Interfaith Medical Center
International Journal of Mental Health | Year: 2017

The utilization of restraints is an important quality measure of psychiatric services including the emergency and inpatient services. The practice, however, continues to generate controversy and differing opinions in terms of its ethics and clinical utility. Prompt identification of patient and environmental factors that are most frequently associated with the need for restraints may provide useful tools to help clinicians as they triage patients in psychiatric emergency settings. Proactive measures such as behavioral interventions can reduce the need for restraints and improve the quality of care provided to patients. We conducted a systematic retrospective review of all restraint orders between January 2016 and June 2016 in the psychiatry emergency of a community hospital in an urban setting. Data was analyzed using descriptive statistics and Chi-square to determine associations between patient demographic characteristics, primary diagnoses and the use of restraints. Results show that 2.9 percent of patients in the present study required restraints. Manual hold was by far the most utilized (88.4%); 53.7 percent of all the patients had a positive urine toxicology for illicit substances, mostly Marijuana (31.6%). We also reported a significant association between the patient’s primary diagnosis and the frequency of restraints (p = 0.004), the most frequent diagnosis being the schizophrenia spectrum (69.5%).In conclusion, our study presents characteristics and descriptors of patients who required restraints. An early identification of patients’ diagnosis and any co-morbid substance abuse and a prompt and proactive management of patients may reduce the need for restraints in psychiatric emergency room settings. © 2017 Taylor & Francis


Iqbal S.,Interfaith Medical Center | Iqbal S.,New York Methodist Hospital | Browne-Mcdonald V.,Interfaith Medical Center | Browne-Mcdonald V.,New York Methodist Hospital | Cerulli M.A.,New York Methodist Hospital
Digestive Diseases and Sciences | Year: 2010

We planned to investigate the recent trends for colorectal cancer (CRC) screening in human immunodeficiency virus (HIV) as compared to non-HIV by interviewing consecutive patients in outpatient clinics during September 2007. Out of a total of 300 patients interviewed, 205 met the inclusion criteria. One hundred and fourteen were HIV-infected, while 91 were non-HIV. HIV received more office visits per year. Despite the high incidence of adenomas on screening colonoscopy, HIV patients were less likely to undergo any type of CRC screening test. A higher number (≥10) of annual clinic visits and the presence of co-morbid conditions were associated with being up-to-date for CRC screening in HIV patients. Conclusion CRC screening is underutilized in HIV patients. Multiple office visits per year are associated with being up-to-date for CRC screening. Hence, increasing patients' compliance with office visits and educating them about the importance of CRC screening may indirectly increase compliance with CRC screening. © 2009 Springer Science+Business Media, LLC.


The International Association of HealthCare Professionals is pleased to welcome Eddy Jacques Vincent, MD, Obstetrician and Gynecologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. He is a highly trained and qualified obstetrician and gynecologist with a vast expertise in all facets of his work, especially infertility. Dr. Vincent has been in practice for over 40 years and is currently serving patients at his private practice located in Brooklyn, New York. He is also on staff at Interfaith Medical Center in Brooklyn, New York, where he teaches residents, medical students, and nurse practitioners. Dr. Vincent attended the University of Haiti where he received his Medical Degree in 1968. He subsequently completed his internship at Catholic Medical Center, residencies at the New York Methodist Hospital and the University of Haiti, and a fellowship at Northwell Health. Dr. Vincent maintains a professional membership with the American Congress of Obstetricians and Gynecologists, allowing him to keep up-to-date in his challenging field. He attributes his success to his hard work, perseverance, providing good care, and having compassion for his patients. When he is not assisting patients, Dr. Vincent enjoys traveling, reading, and watching movies. Learn more about Dr. Vincent by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics.  Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review.  FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise.  A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life.  For more information about FindaTopDoc, visit:http://www.findatopdoc.com


Khanal N.,Creighton University | Upadhyay S.,Creighton University | Dahal S.,Interfaith Medical Center | Bhatt V.R.,University of Nebraska Medical Center | Silberstein P.T.,Creighton University
Therapeutic Advances in Medical Oncology | Year: 2015

Background: Pancreatic cancer accounts for approximately 7% of all cancer deaths. More than half of all pancreatic cancers are stage IV at diagnosis, where systemic chemotherapy is used with the goal of life prolongation as well as palliation. The patient characteristics and health system factors that drive the use of systemic therapy are unknown. Method: This is a retrospective study of stage IV pancreatic cancer patients (n = 140,210) diagnosed between 2000 and 2011 in the NCDB. NCDB contains approximately 70% of new cancer diagnosis from more than 1500 accredited cancer programs in the United States and Puerto Rico. Chi-squared test was used to determine any differences in characteristics of patients who did or did not receive systemic therapy. Results: Our study demonstrated that only 49.1% of stage IV pancreatic cancer patients received systemic therapy. The use of systemic therapy is significantly lower in female, African American/Hispanic, patients older than 40 years, those without insurance or with Medicare and Medicaid, higher Charlson Comorbidity Score, poor economic and educational status and in nonacademic centers. Conclusions: This is the largest study to evaluate the determinants of systemic therapy use in stage IV pancreatic cancer. The use of systemic therapy was significantly lower in patients older than 40 years, lower educational status, nonprivate insurance and with higher Charlson Comorbidity Scores. In addition, the use of systemic therapy was lower with female sex, African Americans/Hispanic, and lower socio-economic status. Understanding the barriers in the use of systemic therapy as well as appropriate utilization of systemic therapy can both optimize cancer care. © The Author(s), 2015.


Kunwar S.,University of New England at Biddeford | Devkota A.R.,Brown University | Ghimire D.K.C.,Interfaith Medical Center
Rheumatology International | Year: 2016

Fostamatinib is a selective inhibitor of spleen tyrosine kinase which has a role in the pathogenesis of RA. Multiple RCTs have been performed to study the effects of fostamatinib. The objective of this study was to perform a meta-analysis to analyze the efficacy and safety of fostamatinib in the management of RA. We searched PubMed, EMBASE and Cochrane CENTRAL through 11/9/15. Random effect model was used to estimate odds ratio (OR) and 95 % confidence interval. We measured outcomes with efficacy analysis using ACR20/50/70 response criteria and safety with adverse events. Five studies were included in the meta-analysis with total of 2105 patients including 1419 in fostamatinib group and 686 in placebo. Fostamatinib was effective in achieving ACR20, ACR50 and ACR70 responses compared to placebo (48 vs. 32.8 %, OR 1.86, 95 % CI 1.32–2.62, P = 0.0004, I2 63 %; 26.4 vs. 12.5 %, OR 2.50, 95 % CI 1.93–3.23, P < 0.00001, I2 0 % and 12.7 vs. 4.4 %, OR 3.00, 95 % CI 1.99–4.51, P < 0.00001, I2 0 %, respectively). Response to fostamatinib was rapid and significant effect on ACR20 response was seen by week 1 (OR 3.70, 95 % CI 2.33–5.87, P < 0.00001, I2 42 %). Safety analysis showed an increased risk of infection (OR 1.59, 95 % CI 1.2–2.11; P = 0.001; I2 0 %), diarrhea (OR 3.54; 95 % CI 2.43–5.16; P < 0.00001; I2 2 %), hypertension (OR 2.55, 95 % CI 1.54–4.22, P = 0.0003; I2 42 %) and neutropenia (OR 5.68, 95 % CI 1.97–16.42, P = 0.001, I2 35 %) and showed a trend toward the increase in ALT ≥3 times ULN (OR 1.76, 95 % CI 0.99–3.13; P = 0.05; I2 0 %). This meta-analysis concludes that fostamatinib has moderate effect in the treatment of RA with mostly mild-to-moderate adverse events and dose-dependent, transient neutropenia and hypertransaminasemia. © 2016, Springer-Verlag Berlin Heidelberg.


Violaris K.,Morgan Stanley | Carbone T.,Valley Hospital | Bateman D.,Morgan Stanley | Olawepo O.,Peninsula Hospital Center | And 2 more authors.
American Journal of Perinatology | Year: 2010

We compared the efficacy and safety of fluconazole and nystatin oral suspensions for the prevention of systemic fungal infection (SFI) in very low birthweight infants. A prospective, randomized clinical trial was conducted over a 15-month period, from May 1997 through September 1998, in 80 preterm infants with birthweights <1500 g. The infants were randomly assigned to receive oral fluconazole or nystatin, beginning within the first week of life. Prophylaxis was continued until full oral feedings were attained. Blood and urine cultures were obtained at enrollment and then weekly thereafter. Thirty-eight infants were randomly assigned to receive oral fluconazole (group I), and 42 infants were assigned to receive nystatin (group II). Birthweight, gestational age, and risk factors for fungal colonization and SFI at the time of randomization and during the hospital course were similar in both groups. SFI developed in two infants (5.3%) in group I and six infants (14.3%) in group II. The difference between these two rates was not statistically significant (relative risk, 0.37; 95% confidence interval, 0.08 to 1.72). There were no deaths in group I and six deaths in group II (p=0.03). Two infants died of neonatal sepsis, and four deaths were related to necrotizing enterocolitis and/or spontaneous intestinal perforation. No deaths were due to SFI. Enrollment was halted before completion and the study did not attain adequate power to detect a hypothesized drop in SFI rate from 15 to 5%. Although the results cannot justify any conclusion about the relative efficacy of fluconazole versus nystatin in prevention of SFI, the significantly higher mortality rate in the nystatin group raises questions about the relative safety of this medication.


Parasramka S.,Interfaith Medical Center | Dufresne A.,Interfaith Medical Center
Journal of Cardiology Cases | Year: 2012

Isolated anomalous origin of right coronary artery is a rare developmental anomaly which is mostly asymptomatic and is discovered incidentally. We present a case of a 21-year-old male who presented with chest pain and was found to have anomalous origin of right coronary artery from pulmonary artery for which he underwent prompt surgical correction. © 2011 Japanese College of Cardiology.


Moon K.-H.,Interfaith Medical Center
International Journal of Biomedical Science | Year: 2012

Introduction: Radiographic pathology of severe osteoarthritis of the knee (OAK) such as severe osteophyte at tibial spine (TS), compartment narrowing, marginal osteophyte, and subchondral sclerosis is well known. Kellgren-Lawrence grading system, which is widely used to diagnose OAK, describes narrowingmarginal osteophyte in 4-grades but uses osteophyte at TS only as evidence of OAK without detailed-grading. However, kinematically the knee employs medial TS as an axis while medial and lateral compartments carry the load, suggesting that early OAK would occur sooner at TS than at compartment. Then, Kellgren- Lawrence system may be inadequate to diagnose early-stage OAK manifested as a subtle osteophyte at TS without narrowing-marginal osteophyte. This undiagnosed-OAK will deteriorate becoming a contributing factor in an increasing incidence of OAK. Methods: This study developed a radiographic OAK-marker based on both osteophyte at TS and compartment narrowing-marginal osteophyte and graded as normal, mild, moderate, and severe. With this marker, both knee radiographs of 1,728 patients with knee pain were analyzed. Results: Among 611 early-stage mild OAK, 562 or 92% started at TS and 49 or 8% at compartment. It suggests the initial development site of OAK, helping develop new site-specific radiographic classification system of OAK accurately to diagnose all severity of OAK at early, intermediate, or late-stage. It showed that Kellgren-Lawrence system missed 92.0% of early-stage mild OAK from diagnosis. Conclusions: A subtle osteophyte at TS is the earliest radiographic sign of OAK. A new radiographic classification system of OAK was suggested for accurate diagnosis of all OAK in severity and at stage. © 2012 Ki-Ho Moon.


Yogarajah M.,Interfaith Medical Center | Sivasambu B.,Interfaith Medical Center
BMJ Case Reports | Year: 2015

Legionnaires disease is a pneumonic illness with multisystem involvement. In 1987, Haines et al reported the only reported case of isolated renal disease of legionellosis without concurrent respiratory disease. A 62-year-old man presented with generalised weakness and malaise and watery diarrhoea, and was found to have acute kidney injury on admission. He was initially managed as acute gastroenteritis complicated with dehydration and acute kidney injury with intravenous hydration. Despite adequate hydration, his renal function was worsening day by day. Later in the course of his sickness he developed pneumonic illness and was diagnosed with Legionnaires disease after a positive urine antigen test. We are reporting the second case of Legionnaires disease presenting as an isolated acute kidney injury in the absence of respiratory symptoms on presentation. Copyright 2015 BMJ Publishing Group. All rights reserved.

Loading Interfaith Medical Center collaborators
Loading Interfaith Medical Center collaborators